Aurora Cannabis signs deal worth USD 3.2 billion to buy MedReleaf
Date: 2018-05-15   Author: Dhananjay Punekar  Category: #market

Aurora Cannabis Inc., a licensed producer of medical marijuana, has apparently decided to acquire MedReleaf, a notable medical cannabis manufacturer, for USD 3.2 billion in an all-stock bid. According to Neil Closner, CEO of MedReleaf, this is one of the biggest deals signed so far across Canada’s emerging medical cannabis sector.

In the event that the agreement receives the nod of approval, it would lead to the creation of a combined entity capable of manufacturing over 570,000 kgs of medical marijuana yearly. Reportedly, the country is likely to legalize the use of recreational marijuana and the strategy is likely to benefit both the Canada-based firms.

Analysts estimate that the combined production ability of both the firms will fulfill over two-thirds of the overall cannabis demand across the Canadian market in 2019. Terry Booth, the CEO of Aurora Cannabis, has stated that the deal will provide the firm with an opportunity to tap the expansive global medical marijuana market. A key official of MedReleaf is of the view that the firm’s acquisition by Aurora will provide the shareholders an immediate premium.

Reliable sources cite that the deal will provide USD 29.44 for each MedReleaf Share, an eighteen percent increase over its closing stock price at USD 24.90 last Friday. After the announcement of the acquisition deal, MedReleaf’s stock price increased on the Toronto Stock Exchange on Monday. The deal between the two cannabis producing giants will escalate the expansion of Canada medical marijuana industry, claim experts.

It has been speculated that the joint entity will have a market capitalization of approximately USD 7.44 billion – a figure commendably more than that of Canopy Growth Corporation, the largest licensed producer of medical cannabis in Canada.

Earlier, Aurora had also acquired CanniMed, another Canada-based medical marijuana producer, for USD 1.1 billion in an all stock & cash transaction.



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

Rising incidences of GI disorders to drive endoscopy market over 2018-2024
Author: Paroma Bhattacharya

The extensive prevalence of gastrointestinal disorders among the geriatric and pediatric population will reportedly drive endoscopy market trends. As per estimates, in the U.S. almost 3.5 million people visit the physi...


5 soundproof curtains market trends to watch out for over 2018-2024
Author: Paroma Bhattacharya

Rising noise levels and strict legislative steps to protect against the problems caused by noise pollution have reportedly resulted in the expansion of soundproof curtains market. Public institutes like movie theaters,...


Rising demand for electronic products to drive vacuum pump market over 2018-2025
Author: Saipriya Iyer

The robust technological enhancement in electronic components will reportedly be a prime factor driving vacuum pump market. With the rise in middle class incomes and the subsequent increase in affordability and standar...